Dividend Assets Capital, LLC Viatris Inc Transaction History

Dividend Assets Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$9.02 - $10.29 $5,754 - $6,565	-638 Reduced 64.19%	356 $4,000
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $8,528 - $11,305	-978 Reduced 49.59%	994 $11,000
Q3 2022 Oct 18, 2022	SELL	$8.48 - $11.13 $178 - $233	-21 Reduced 1.05%	1,972 $17,000
Q2 2022 Jul 15, 2022	SELL	$9.95 - $12.27 $258 - $319	-26 Reduced 1.29%	1,993 $21,000
Q4 2021 Feb 23, 2022	SELL	$12.09 - $14.68 $5,464 - $6,635	-452 Reduced 18.29%	2,019 $27,000
Q3 2021 Nov 01, 2021	SELL	$13.25 - $15.13 $4,346 - $4,962	-328 Reduced 11.72%	2,471 $33,000
Q1 2021 Apr 28, 2021	SELL	$13.59 - $18.54 $2,527 - $3,448	-186 Reduced 6.23%	2,799 $39,000
Q4 2020 Jan 22, 2021	BUY	$14.3 - $18.74 $42,685 - $55,938	2,985 New	2,985 $56,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Dividend Assets Capital, LLC with notifications on news.